Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Available NCT07780110

Compassionate Use of Vonsetamig

Conditions: Plasma Cell Mediated, Antibody Mediated

Sponsor: Regeneron Pharmaceuticals

Summary

Provide Compassionate Use of Vonsetamig

Eligibility Criteria

Eligibility will be determined during the application review process.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07780110). StuddyBuddy aggregates publicly available trial information.